Latest News by Industry
BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Amneal Pharmaceuticals, Inc. (AMRX) on Friday reported a loss of $6.9 million in its first quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of 5 cents. Earnings, adjusted for one-time gains and costs, were 12 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 9 cents per share.
The pharmaceutical company posted revenue of $557.5 million in the period.
Amneal expects full-year earnings in the range of 40 cents to 50 cents per share, with revenue in the range of $2.25 billion to $2.35 billion.
The company's shares closed at $1.84. A year ago, they were trading at $3.73.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a AMRX">Zacks stock report on AMRX at https://www.zacks.com/ap/AMRX